To the Editor: We appreciate the opportunity to respond to the comments of Knoppers and colleagues1 regarding the American College of Medical Genetics and Genomics (ACMG) statement, “Patient re-contact after revision of genomic test results: points to consider,”2 recently e-published before print in Genetics in Medicine. The comments in Knoppers’ letter, however, reflect a misunderstanding of our document and conflate the clinical and research settings. We reiterate that the ACMG statement reflects practice of American clinical geneticists who provide direct patient services. It does not speak to the research setting.

Current American clinical and legal standards and fundamental ethical principles inform our Points to Consider. We clearly state that reasonable efforts should be made by providers (not necessarily only physicians) to contact the patient (Points to Consider #8). These efforts may encounter “resource constraints” that may be similar or dissimilar to those in the research setting. The letter of Knoppers et al. points out that the American Society of Human Genetics draft position3 limits researchers’ “duty to re-contact” to the duration of the project funding. On the other hand, clinicians’ concerns that patients be properly informed of revised interpretation may extend indefinitely after the original consultation. Given the practicalities of contacting patients potentially years after the results of a genetic test were first reported, it is neither reasonable nor realistic to promise more than providers can deliver. Despite best efforts on the part of laboratories and clinicians, re-contact cannot be guaranteed unless the patient initiates the process.

The ACMG statement does not place sole responsibility for re-contact on anyone; rather the statement stresses a collaborative approach. As highlighted in our Points to Consider, the ACMG recognizes that its position may well evolve with developments in molecular technology and variant interpretation, electronic record and communication technology, and the legal environment. Therefore, the ACMG Points to Consider is meant as the best approach on these difficult issues in the current context of clinical care.